More on ATHE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Alterity Therapeutics (NQ:ATHE)
Delayed: 4.55 +0.06 (1.34%)
Prev. Close $4.49  
Open$4.40 
52 Wk High$ 
52 Wk Low$ 
Day High$4.72 
Day Low$4.40 
P/E N/A  
EPS$ 
Volume13,202 

Friends, Peers and Foes (?): PBN, ATH, ATH.AX ATHDA (more...)

Aug 11, 2026 07:21 AM Craig-Hallum Starts Alterity Therapeutics (ATHE) at Buy
Jul 30, 2026 07:25 AM Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
Jun 29, 2026 04:31 PM Jones Trading Starts Alterity Therapeutics (ATHE) at Buy
Jun 23, 2026 07:58 PM Form 4 ALTERITY THERAPEUTICS For: Jun 15 Filed by: Babarczy Julian Michael
Jun 23, 2026 07:38 PM Form 4 ALTERITY THERAPEUTICS For: Jun 15 Filed by: Gozlan Lawrence Bernard
Jun 16, 2026 08:04 AM Ladenburg Thalmann Assumes Alterity Therapeutics (ATHE) at Buy
Jun 3, 2026 06:05 AM Form 6-K ALTERITY THERAPEUTICS For: Jun 30
May 29, 2026 06:08 AM Form 6-K ALTERITY THERAPEUTICS For: May 31
May 19, 2026 07:25 AM Alterity Therapeutics presents data supporting ATH434 Phase 3 advance in MSA
May 19, 2026 07:25 AM Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
View All Articles

Entities mentioned with ATHE

View All Entities